When.com Web Search

  1. Ads

    related to: cremo cologne target

Search results

  1. Results From The WOW.Com Content Network
  2. 10 of the Most Captivating Colognes for Men

    www.aol.com/entertainment/10-most-captivating...

    18.21 Man Made Men's Cologne 18.21 Man Made Men’s Cologne, Tobacco Vanilla Fragrance - Long-Lasting Eau de Parfum for Men, Sweet Scent with Woodsy Undertones - Eau de Toilette with ...

  3. The Best Citrus Colognes for Men

    www.aol.com/entertainment/best-citrus-colognes...

    This eau de parfum is relatively new: it was developed in 2020 as a fragrance for both women and men. Xerjoff is a luxury Italian perfumer, and most people would consider its creations to be ...

  4. Edgewell Personal Care - Wikipedia

    en.wikipedia.org/wiki/Edgewell_Personal_Care

    In September 2020, Edgewell announced it was acquiring the shaving products brand CREMO for an all-cash transaction of $235 million. The acquisition was completed in September 2020. [14] [15] In November 2021, Edgewell announced it had acquired women's body brand Billie in an all-cash transaction at a purchase price $310 million. [16]

  5. Aqua Velva - Wikipedia

    en.wikipedia.org/wiki/Aqua_Velva

    Aqua Velva was first trademarked in 1917 by the J.B. Williams Company [2] and later acquired by the Beecham Group in 1982, [3] SmithKline Beecham in 1989, [4] then by GlaxoSmithKline from 2000 until it was sold to Combe Incorporated in 2002. [5]

  6. Best CD rates for February 20, 2025 - AOL

    www.aol.com/best-cd-rates-today-need-stability...

    At the conclusion of its first rate-setting policy meeting of the year, on January 29, 2025, the Federal Reserve announced it was leaving the federal funds target interest rate at 4.25% to 4.50% ...

  7. What one man's 'escape' from Alzheimer's might tell us about ...

    www.aol.com/one-mans-escape-alzheimers-might...

    A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer insights on new preventive and therapeutic avenues?